| NCT02141100 | Kjeld Schmiegelow|Aalborg University Hospital|Aarhus University Hospital Skejby|Odense University Hospital | Non-Hodgkin Lymphoma | 2014-07 | PHASE1|PHASE2 |
| NCT00184041 | University of Southern California | Acute Lymphoblastic Leukemia | 2004-07 | PHASE2 |
| NCT00439296 | Therapeutic Advances in Childhood Leukemia Consortium|Abbott | Recurrent Pediatric ALL|Relapsed Pediatric ALL|Acute Lymphoblastic Leukemia|Refractory Pediatric ALL | 2006-05-22 | PHASE1|PHASE2 |
| NCT00588536 | Memorial Sloan Kettering Cancer Center | Langerhans Cell Histiocytosis | 1995-01 | PHASE2 |
| NCT00504660 | M.D. Anderson Cancer Center | Anaplastic Glioma of Brain|Glioblastoma Multiforme|Brain Cancer | 2003-09 | PHASE2 |
| NCT00176462 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI) | Acute Lymphocytic Leukemia | 2001-02 | PHASE2 |
| NCT00002744 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1996-05 | PHASE3 |
| NCT02101853 | National Cancer Institute (NCI) | Recurrent B Acute Lymphoblastic Leukemia | 2014-12-17 | PHASE3 |
| NCT01451515 | St. Jude Children´s Research Hospital|National University of Singapore | Lymphoblastic Lymphoma | 2012-05-25 | PHASE2 |
| NCT04043494 | University Hospital Muenster|Deutsche Krebshilfe e.V., Bonn (Germany) | Lymphoblastic Lymphoma, Childhood | 2019-08-23 | PHASE3 |
| NCT00003423 | United Kingdom Children´s Cancer Study Group | Lymphoma | 1995-05 | PHASE3 |
| NCT00005823 | Leukemia Research Fund | Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 1998-12 | PHASE3 |
| NCT00005596 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2000-04 | PHASE3 |
| NCT01228331 | Universit?tsklinikum Hamburg-Eppendorf | Leukemia | 2010-10 | PHASE2|PHASE3 |
| NCT00199056 | Goethe University | Adult Acute Lymphocytic Leukemia | 1999-10 | PHASE4 |
| NCT00002812 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1996-09 | PHASE3 |
| NCT00003437 | Medical Research Council | Leukemia | 1997-01 | PHASE3 |
| NCT00016302 | National Cancer Institute (NCI) | T-cell Childhood Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia | 2001-04 | NA |
| NCT00005603 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2000-03 | PHASE3 |
| NCT02419469 | M.D. Anderson Cancer Center|Jazz Pharmaceuticals | Leukemia|Precursor-B Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma|Lymphoma | 2015-11-13 | PHASE2 |
| NCT00004056 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1999-10 | PHASE1 |
| NCT00198991 | Goethe University|Deutsche Krebshilfe e.V., Bonn (Germany)|German Federal Ministry of Education and Research | Adult Acute Lymphocytic Leukemia | 2003-04 | PHASE4 |
| NCT03914625 | National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma|Down Syndrome | 2019-07-03 | PHASE3 |
| NCT00199017 | Johann Wolfgang Goethe University Hospital | Lymphoma, Lymphoblastic | 2004-04 | PHASE4 |
| NCT07072585 | Children´s Oncology Group | Stage II T Lymphoblastic Leukemia+Lymphoma|Stage III T Lymphoblastic Leukemia+Lymphoma|Stage IV T Lymphoblastic Leukemia+Lymphoma|T Acute Lymphoblastic Leukemia|T Lymphoblastic Lymphoma | 2026-06-28 | PHASE2|PHASE3 |
| NCT06533748 | St. Jude Children´s Research Hospital|Pfizer|Amgen | Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma | 2025-01-23 | PHASE2 |
| NCT00275106 | Children´s Cancer and Leukaemia Group|European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma | Lymphoma | 2004-09 | PHASE3 |
| NCT00002665 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Leukemia|Neutropenia|Thrombocytopenia | 1995-07 | PHASE2 |
| NCT00199004 | Johann Wolfgang Goethe University Hospital | Adult Acute Lymphocytic Leukemia | 2004-04 | PHASE4 |
| NCT00002798 | National Cancer Institute (NCI) | Childhood Acute Erythroleukemia (M6)|Childhood Acute Megakaryocytic Leukemia (M7)|Childhood Acute Monoblastic Leukemia (M5a)|Childhood Acute Monocytic Leukemia (M5b)|Childhood Acute Myeloblastic Leukemia With Maturation (M2)|Childhood Acute Myeloblastic Leukemia Without Maturation (M1)|Childhood Acute Myelomonocytic Leukemia (M4)|Childhood Myelodysplastic Syndromes|Chronic Myelomonocytic Leukemia|de Novo Myelodysplastic Syndromes|Refractory Anemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation|Refractory Anemia With Ringed Sideroblasts|Secondary Myelodysplastic Syndromes|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies | 1996-08 | PHASE3 |
| NCT00430118 | University Hospital Schleswig-Holstein | Leukemia | 2000-07 | PHASE3 |
| NCT00369317 | Children´s Oncology Group|National Cancer Institute (NCI) | Childhood Acute Basophilic Leukemia|Childhood Acute Eosinophilic Leukemia|Childhood Acute Erythroleukemia (M6)|Childhood Acute Megakaryocytic Leukemia (M7)|Childhood Acute Minimally Differentiated Myeloid Leukemia (M0)|Childhood Acute Monoblastic Leukemia (M5a)|Childhood Acute Monocytic Leukemia (M5b)|Childhood Acute Myeloblastic Leukemia With Maturation (M2)|Childhood Acute Myeloblastic Leukemia Without Maturation (M1)|Childhood Acute Myelomonocytic Leukemia (M4)|Childhood Myelodysplastic Syndromes|de Novo Myelodysplastic Syndromes|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies | 2007-03 | PHASE3 |
| NCT03117751 | St. Jude Children´s Research Hospital|Incyte Corporation|Amgen|Servier | Acute Lymphoblastic Leukemia|Acute Lymphoblastic Lymphoma | 2017-03-29 | PHASE2|PHASE3 |
| NCT00002531 | Johann Wolfgang Goethe University Hospital | Leukemia | 1993-01 | PHASE2 |
| NCT02828358 | National Cancer Institute (NCI) | Acute Leukemia of Ambiguous Lineage|B Acute Lymphoblastic Leukemia|Mixed Phenotype Acute Leukemia | 2017-04-01 | PHASE2 |
| NCT00266136 | University Hospital Muenster|Deutsche Krebshilfe e.V., Bonn (Germany)|German Federal Ministry of Education and Research | Acute Myeloid Leukemia | 1999-06 | PHASE3 |
| NCT01117441 | University Hospital Schleswig-Holstein|Deutsche Krebshilfe e.V., Bonn (Germany) | Leukemia | 2010-06 | PHASE3 |
| NCT00004228 | Children´s Oncology Group|National Cancer Institute (NCI) | Lymphoma | 2000-06 | PHASE3 |
| NCT00186966 | Dutch Childhood Oncology Group|International BFM Study Group|St. Jude Children´s Research Hospital | Acute Myeloid Leukemia | 2002-03 | PHASE3 |
| NCT00002816 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1996-12 | PHASE3 |
| NCT03571321 | University of Chicago|Incyte Corporation | Acute Lymphoblastic Leukemia|ALL, Childhood|ALL | 2019-05-28 | PHASE1 |
| NCT00343369 | Universit?tsklinikum Hamburg-Eppendorf | Leukemia | 2003-01 | NA |
| NCT01156883 | Gruppo Italiano Malattie EMatologiche dell´Adulto | Leukemia | 2010-04 | NA |
| NCT01190930 | Children´s Oncology Group|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Lymphoblastic Lymphoma|Ann Arbor Stage I B Lymphoblastic Lymphoma|Ann Arbor Stage II B Lymphoblastic Lymphoma|Childhood B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Childhood B Lymphoblastic Lymphoma|Down Syndrome|Hypodiploid B Acute Lymphoblastic Leukemia|Philadelphia Chromosome Positive | 2010-08-09 | PHASE3 |
| NCT00002944 | Children´s Oncology Group|National Cancer Institute (NCI) | Brain Tumors|Central Nervous System Tumors | 1997-04 | PHASE3 |
| NCT00002514 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Medical Research Council | Leukemia | 1993-05-07 | PHASE3 |
| NCT03007147 | Children´s Oncology Group|EsPhALL|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia|Mixed Phenotype Acute Leukemia|T Acute Lymphoblastic Leukemia | 2017-08-08 | PHASE3 |
| NCT00005585 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2000-04 | PHASE3 |
| NCT00005945 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2000-06 | PHASE3 |
| NCT00549848 | St. Jude Children´s Research Hospital|National Cancer Institute (NCI)|Enzon Pharmaceuticals, Inc.|National Institute of General Medical Sciences (NIGMS) | Acute Lymphoblastic Leukemia | 2007-10-29 | PHASE3 |
| NCT02521493 | Children´s Oncology Group|National Cancer Institute (NCI) | Acute Myeloid Leukemia|Down Syndrome|Myelodysplastic Syndrome|Myeloid Leukemia Associated With Down Syndrome|Myeloproliferative Neoplasm | 2015-12-23 | PHASE3 |
| NCT00408005 | National Cancer Institute (NCI) | T Acute Lymphoblastic Leukemia|T Lymphoblastic Lymphoma | 2007-01-30 | PHASE3 |
| NCT00109837 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Leukemia | 2005-04 | PHASE2 |
| NCT02894645 | National University Hospital, Singapore | Acute Lymphoblastic Leukemia (ALL) | 2008-10 | PHASE4 |
| NCT06317662 | National Cancer Institute (NCI) | Acute Leukemia of Ambiguous Lineage|B Acute Lymphoblastic Leukemia | 2025-06-05 | PHASE2 |
| NCT00003671 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1998-12 | PHASE2 |
| NCT06210750 | National Cancer Institute (NCI) | T Acute Lymphoblastic Leukemia|T Lymphoblastic Lymphoma | 2024-08-09 | PHASE2 |
| NCT00002658 | Medical Research Council | Leukemia|Neutropenia | 1994-01 | PHASE3 |
| NCT00866307 | Children´s Oncology Group|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia | 2009-02-23 | PHASE1 |
| NCT00002590 | Children´s Oncology Group|National Cancer Institute (NCI) | Lymphoma | 1994-07 | PHASE2 |
| NCT02660762 | Sun Yat-sen University | Leukaemia,Lymphoblastic | 2016-01 | PHASE2 |
| NCT02883049 | National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia, BCR-ABL1-Like|Central Nervous System Leukemia|Testicular Leukemia | 2012-02-29 | PHASE3 |
| NCT00075725 | Children´s Oncology Group|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia | 2003-12-29 | PHASE3 |
| NCT00022126 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2002-11 | PHASE2 |
| NCT00103285 | Children´s Oncology Group|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia | 2005-04-11 | PHASE3 |
| NCT00003593 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 1999-06 | PHASE3 |
| NCT00866749 | M.D. Anderson Cancer Center | Lymphoblastic Leukemia|Lymphoblastic Lymphoma | 2006-09-12 | PHASE2 |
| NCT00002517 | European Organisation for Research and Treatment of Cancer - EORTC | Leukemia|Myelodysplastic Syndromes | 1993-03 | PHASE3 |
| NCT00671034 | Children´s Oncology Group|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia | 2008-07-21 | PHASE3 |
| NCT00003728 | European Organisation for Research and Treatment of Cancer - EORTC | Leukemia|Lymphoma | 1998-12 | PHASE3 |
| NCT00002701 | European Organisation for Research and Treatment of Cancer - EORTC|Gruppo Italiano Malattie EMatologiche dell´Adulto | Leukemia | 1995-10 | PHASE3 |
| NCT02723994 | Incyte Corporation|Children´s Oncology Group | Leukemia | 2016-09-30 | PHASE2 |
| NCT02912676 | Kjeld Schmiegelow|Danish Child Cancer Foundation|Nordic Society for Pediatric Hematology and Oncology | Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma | 2016-10 | PHASE1|PHASE2 |
| NCT06390319 | St. Jude Children´s Research Hospital|AbbVie | T-cell Acute Lymphoblastic Leukemia|T-cell Lymphoma|Mixed Phenotype Acute Leukemia | 2024-12-27 | PHASE2 |
| NCT06336395 | National University Hospital, Singapore | B Lymphoblastic Leukemia | 2020-03-04 | PHASE2 |
| NCT00558519 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Leukemia | 2008-03-12 | PHASE2 |
| NCT06351306 | Columbia University | Acute Myeloid Leukemia | 2024-04-01 | PHASE2 |
| NCT03959085 | Children´s Oncology Group|National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma|Central Nervous System Leukemia|Mixed Phenotype Acute Leukemia|Testicular Leukemia | 2019-10-31 | PHASE3 |
| NCT00550992 | Dutch Childhood Oncology Group|BFM Germany|CORS Monza Italy|Associazione Italiana Ematologia Oncologia Pediatrica|Australian and New Zealand Children´s Oncology Group|BFM Austria|CLCG France Belgium Portugal|COALL Germany|CPH, Czech republic|DFCI consortium USA|FRALLE France|Hong Kong Government|MD Anderson USA|NOPHO Scandinavian countries|PINDA, Chile|PPLLSG Poland|Seattle USA|SJCRH USA|UKCCSG United Kingdom | Leukemia | 2006-01 | NA |
| NCT02112916 | National Cancer Institute (NCI) | Adult T Acute Lymphoblastic Leukemia|Ann Arbor Stage II Adult Lymphoblastic Lymphoma|Ann Arbor Stage II Childhood Lymphoblastic Lymphoma|Ann Arbor Stage III Adult Lymphoblastic Lymphoma|Ann Arbor Stage III Childhood Lymphoblastic Lymphoma|Ann Arbor Stage IV Adult Lymphoblastic Lymphoma|Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma|Childhood T Acute Lymphoblastic Leukemia | 2014-10-04 | PHASE3 |
| NCT03150693 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia | 2017-09-20 | PHASE3 |
| NCT00764907 | University Hospital, Motol | Leukemia | 2002-11 | PHASE3 |
| NCT00613457 | Associazione Italiana Ematologia Oncologia Pediatrica | Leukemia | 2000-09 | PHASE3 |
| NCT06124157 | National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia | 2025-05-30 | PHASE2 |